(Q38119251)

29 August 2017

The role of the androgen receptor in triple-negative breast cancer (English)

1 reference

29 August 2017

1 reference

Payal D Shah

1

1 reference

PubMed ID

23826776

29 August 2017

Ayca Gucalp

series ordinal

2

1 reference

PubMed ID

23826776

29 August 2017

Tiffany A Traina

series ordinal

3

1 reference

29 August 2017

1 July 2013

1 reference

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

4

1 reference

29 August 2017

351-360

1 reference

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

29 August 2017

1 reference

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

21 January 2018

1 reference

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

21 January 2018

1 reference

Immunohistochemical demonstration of androgen receptor in breast cancer and its relationship to other prognostic factors

21 January 2018

1 reference

Expression of androgen receptors in primary breast cancer

21 January 2018

1 reference

Androgen receptor expression and breast cancer survival in postmenopausal women

21 January 2018

1 reference

Androgen receptors frequently are expressed in breast carcinomas: potential relevance to new therapeutic strategies.

21 January 2018

1 reference

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

21 January 2018

1 reference

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

Androgen receptor as a therapeutic target

21 January 2018

1 reference

Targeting the androgen receptor

21 January 2018

1 reference

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.

21 January 2018

1 reference

Low fertility in aging roosters is related to a high plasma concentration of insulin and low testicular contents of ACTH and lactate

21 January 2018

1 reference

Prognostic markers in triple-negative breast cancer

21 January 2018

1 reference

Expression of androgen receptors in triple negative breast carcinomas.

21 January 2018

1 reference

Decreased androgen receptor expression is associated with distant metastases in patients with androgen receptor-expressing triple-negative breast carcinoma.

21 January 2018

1 reference

Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers.

21 January 2018

1 reference

Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers.

21 January 2018

1 reference

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray

21 January 2018

1 reference

Expression of androgen receptor in breast cancer and its significance as a prognostic factor

21 January 2018

1 reference

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

21 January 2018

1 reference

Prognostic relevance of androgen receptor detection in operable breast cancer

21 January 2018

1 reference

Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

21 January 2018

1 reference

The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer.

21 January 2018

1 reference

Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

21 January 2018

1 reference

Role of the androgen receptor in human breast cancer

21 January 2018

1 reference

Androgen receptor mediated growth control of breast cancer and endometrial cancer modulated by antiandrogen- and androgen-like steroids

21 January 2018

1 reference

Combined androgen and antimetabolite therapy of advanced female breast cancerA report of the cooperative breast cancer group

21 January 2018

1 reference

A physiologic role for testosterone in limiting estrogenic stimulation of the breast

21 January 2018

1 reference

Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression

21 January 2018

1 reference

Androgens induce divergent proliferative responses in human breast cancer cell lines.

21 January 2018

1 reference

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

21 January 2018

1 reference

Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

21 January 2018

1 reference

Targeting androgen receptor in estrogen receptor-negative breast cancer

21 January 2018

1 reference

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression

21 January 2018

1 reference

An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity

21 January 2018

1 reference

International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy

21 January 2018

1 reference

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

21 January 2018

1 reference

Androgen receptors as a prognostic and predictive factor in breast cancer.

21 January 2018

1 reference

Mechanism of androgen receptor action

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.13.33

1 reference

29 August 2017

1 reference

PubMed ID

23826776